Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them
申请人:LES LABORATOIRES SERVIER
公开号:US10414754B2
公开(公告)日:2019-09-17
Compounds of formula (I) wherein Ra, Rb, Rc, Rd, T, R3, R4, R5, X, Y and Het are as defined in the description.
Medicinal products containing the same which are useful in treating pathologies involving a deficit in apoptosis, such as cancer, auto-immune diseases, and diseases of the immune system.
式 (I) 的化合物,其中 Ra、Rb、Rc、Rd、T、R3、R4、R5、X、Y 和 Het 如描述中所定义。
含有相同成分的药物产品,可用于治疗涉及细胞凋亡缺陷的病症,如癌症、自身免疫性疾病和免疫系统疾病。